Arkolith/Insider Trading/QNCX/Form 4

Lamond David

DirectorQuince Therapeutics, Inc. (QNCX) · full profile →Form 4 · filed Aug 17, 2023
Net Buying
Open-Market Buys
$326K
Open-Market Sells
$0
Net Open-Market Flow
$326K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 17, 2023Buy(P)25K$1.29$32K2.1M
Aug 16, 2023Buy(P)117K$1.29$151K2.1M
Aug 15, 2023Buy(P)108K$1.32$142K2.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-046402) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML